Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV
Mabel Toribio(Boston College), Steven Grinspoon(Massachusetts General Hospital), Craig A. Sponseller, Mary McCurdy Pate(Alabama State University), Tricia H. Burdo(Temple University), Kathleen V. Fitch(Harvard University), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Markella V. Zanni(Harvard University), Laura Sánchez(Harvard University), Kenneth C. Williams(Boston College)
Cited by 87
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k
Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
|New England Journal of Medicine|2005|1.1k